Dr. Keith Barton is a Consultant Ophthalmologist and Glaucoma Specialist at Moorfields Eye Hospital, Honorary Reader in UCL Institute of Ophthalmology, Co-chair of Ophthalmology Futures Forums and Editor-in-Chief of the British Journal of Ophthalmology.

His areas of interest are the surgical management of glaucoma, especially surgical devices and secondary glaucomas, specifically the management of glaucoma in uveitis, for which he runs a dedicated clinic at Moorfields Eye Hospital. He was the only non American investigator in the Tube versus Trabeculectomy Study and Co-Chair of the Ahmed Baerveldt Comparison Study. He is currently a member of the Primary Tube Versus Trabeculectomy (PTVT) Study Steering Committee, Chief Investigator in the Corneal Ancillary Study to the PTVT Study and a member of the Trial Management Committees of both the NIHR HTA-funded Treatment of Advanced Glaucoma (TAGS) and Lasers in Glaucoma and Ocular Hypertension (LIGHT) Studies.

His medical school education was in Belfast followed by residency training at Moorfields Eye Hospital in London and a fellowship in Cornea and External Eye Disease at the Bascom Palmer Eye Institute, University of Miami. He was Director of the glaucoma service at Moorfields Eye Hospital from 2005 – 2011 and Chairman of the International Glaucoma Association from 2012 to 2017. He has been Editor-in-Chief of the British Journal of Ophthalmology from 2014, Hong Leong Visiting Professor at the National University of Singapore from 2011-204 and 2016-2017 and, more recently, Visiting Professor at the Wenzhou Medical University, China and the New York Eye & Ear Infirmary of Mount Sinai. He has been a trustee of the TFC Frost Charitable Trust since 2015.

Dr.Barton has been invited to lecture on every continent and in 2017 was awarded the Charamis Medal at the Societas Ophthalmologica Europeae for achievement in the field of ophthalmic surgery, gave the Honoured International Keynote Lecture at the American Society of Cataract and Refractive Surgeons, Glaucoma Day in Los Angeles. He is Honorary Treasurer of the International Society for Glaucoma Surgery and founder of ESCRS Glaucoma Day. He organises and runs glaucoma educational symposia which have attracted significant acclaim, including the Moorfields International Glaucoma Symposium (from 2008 – 2020) (www.migs.org.uk). In 2012, Dr Barton co-founded and organised Ophthalmology Futures Forums, industry investor networking events in Ophthalmology, both in Europe and Asia (www.ophthalmology-futures.com) and has twice been voted by The Ophthalmologist magazine as one of the 100 most influential people in Ophthalmology (in 2018 he was voted no. 10 in the world).

Dr.Barton is actively involved in surgical teaching and patient education, organising surgical teaching wetlabs for residents and fellows locally around London as well as in collaboration with the International Society for Glaucoma Surgery. He has produced patient information on aqueous shunt implantation and trabeculectomy that are available online in several languages and which have been awarded the NHS Information Standard in the UK. Additionally, he has co-founded an online resource www.migs.org to help patients and clinicians navigate the proliferation of new glaucoma surgical devices and the associated web-based international glaucoma surgery registry www.IGSR.org for surgeons to record and track glaucoma surgical procedures and outcomes.

Dr. Barton has been involved in charitable work and population-based research in Ghana, West Africa as an Investigator in the Tema Eye Survey and the follow-up Tema Eye Survey II. He regularly takes part in sporting events and has raised £74,000 for the the International Glaucoma Association by cycling 200 miles from London to Paris in 24 hours in 3 successive years. Additionally he completed 5 x 100 mile charity cycle rides for Moorfields Eye Charity from 2013- 2017 as well as 5 marathons, including Boston.